Velorum Therapeutics

formerly Velorum Therapeutics Inc.

Breakthrough medicines unlocking the biology of heme

Velorum Therapeutics was founded in 2023, is headquartered in San Francisco, United States, lists 1–10 employees, and has $500K in recorded funding across 1 round.

Employees
1–10
Founded
2023
Business Model
B2B
Total Funding
$500K
Last Round
$500K Pre-SeedFeb 2024
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 6 investors for this company. The full record is or through the API.

About

Velorum Therapeutics is developing breakthrough medicines by unlocking the biology of heme.

Summary

Velorum Therapeutics is a Biotech company based in San Francisco, United States, founded in 2023. It lists 1–10 employees. It has raised $500K in total across 1 round, most recently a $500K Pre-Seed round in Feb 2024. Investors include Y Combinator, 468 Capital and Jaan Tallinn.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Pre-seedPre-SeedFeb 2024
$500K

Investors

Similar Companies

Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Paratek PharmaceuticalsAcquired

Paratek Pharmaceuticals develops and delivers innovative treatments for serious infectious diseas...

Boston, United States201–500Biotech, Healthcare
ConvertibleTotal funding$1.8BApr 2018

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Velorum Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/velorumtx"><img src="https://indexed.vc/api/badge/company/velorumtx" alt="Velorum Therapeutics on Indexed.vc" width="260" height="76" /></a>